| Ayman Saad, MD | |
|
460 W 10th Ave, Columbus, OH 43210-1240 | |
| (614) 293-3196 | |
| (614) 293-4812 |
| Full Name | Ayman Saad |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 460 W 10th Ave, Columbus, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548470347 | NPI | - | NPPES |
| 0315884 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 22092 (West Virginia) | Secondary |
| 207RH0000X | Internal Medicine - Hematology | 35.134740 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ayman Saad, MD 700 Ackerman Rd Ste 2120, Columbus, OH 43202-1559 Ph: (614) 293-3196 | Ayman Saad, MD 460 W 10th Ave, Columbus, OH 43210-1240 Ph: (614) 293-3196 |
News Archive
About 1 in 4,000 infants has a brain injury known as pre- or perinatal brain lesions, mainly as a result of stroke, with risk factors involving both mothers and babies. Children with early brain lesions that affect one side of the brain often take longer to reach early language milestones; these delays normalize for many but persist for some.
Improvised explosive devices and associated blast injuries have left over 350,000 U.S. service members in Iraq and Afghanistan with an invisible wound: traumatic brain injury.
To protect human health, Endocrine Society members called on the European Commission to adopt science-based policies for regulating endocrine-disrupting chemicals in an opinion piece published today in The Lancet Diabetes & Endocrinology.
Researchers at the Children's Hospital Colorado Breathing Institute, the largest pediatric cystic fibrosis (CF) clinical care center in the U.S., participated in the pivotal international multi-center Phase 3 clinical trial, sponsored by Vertex Pharmaceuticals Incorporated, leading to FDA approval of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor), a highly effective CF treatment, for patients ages 6 through 11 who have at least one copy of the F508del mutation.
CombinatoRx, Incorporated today announced that preclinical data on its discovery of novel synergistic drug combinations for the treatment of cancer will be highlighted at the 101st Annual meeting of the American Association for Cancer Research 2010, April 17-21, in Washington, DC.
› Verified 5 days ago
Sethu M. Madhavan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 10th Ave, Columbus, OH 43210 Phone: 614-293-3387 Fax: 614-366-0073 | |
Amrik Singh Khalsa, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 700 Childrens Dr, Columbus, OH 43205 Phone: 614-722-2000 Fax: 614-722-4966 | |
Samuel Y. Han, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 410 W 10th Ave, Columbus, OH 43210 Phone: 614-293-6255 Fax: 614-293-1456 | |
Dr. Ruchi Bhatia, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Olentangy River Rd, Columbus, OH 43202 Phone: 614-754-5500 Fax: 614-457-9519 | |
Adam T. Ramey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 410 W 10th Ave, Columbus, OH 43210 Phone: 614-293-7499 Fax: 614-366-2360 | |
Albert J. Cook, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 460 W 10th Ave, Columbus, OH 43210 Phone: 614-293-2957 Fax: 614-685-6533 | |
Walter G. Hanel Iv, MD, PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 460 W 10th Ave, Columbus, OH 43210 Phone: 614-293-3196 Fax: 614-293-4812 |